Clinical trials
Risk Reduction clinical trials
Below are recruiting risk reduction clinical trials, each written for real people, not researchers. We’re tracking 63 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07024628Recruiting
Heat safety messages from your doctor
This study tests whether health tips sent by text or email from your family doctor can help you stay safe during heat waves. If you live in Eastern Ontario and have a regular primary care provider, you may be able to join and get these messages.
Ottawa, OntarioAges 18 years+ - NCT07002866Recruiting
PrEP access and adherence study for young women in Uganda
This study tests a program to help adolescent girls and young women at high risk of HIV take PrEP consistently. It aims to improve access and adherence to PrEP, a daily pill that prevents HIV.
St Louis, MissouriAges 15–24 - NCT06618586Recruiting
Social media training for new parents
This study tests if social media can help new parents learn safe sleep practices and reduce infant health risks. You can join if you recently had a healthy baby and plan to care for them at home.
Boston, MassachusettsAges Any age - NCT06961630RecruitingEarly Phase 1
Heart protection after surgery
This trial tests if a personalized approach with blood thinners and statins can reduce heart risks after non-cardiac surgery. It is for adults 45 and older who had a heart injury during or after surgery.
New York, New YorkAges 45 years+ - NCT06959784Enrolling by invitationPhase 4
A study on new diabetes drugs for heart health and remission
This trial tests if newer diabetes medications can reduce heart risk and help achieve diabetes remission in people newly diagnosed with type 2 diabetes. It may be an option if you have not taken diabetes drugs before or stopped them over three months ago, and your blood sugar and weight are in certain ranges.
BeijingAges 30–70 - NCT06926816Recruiting
Genetic testing for cancer risk in young women
This study offers free genetic testing to women ages 25-39 who receive gynecologic care at certain NYU Langone Health clinics. The goal is to find inherited gene changes that may increase risk for ovarian and related cancers, so you can take steps to reduce your risk.
New York, New YorkAges 25–39 - NCT06930885RecruitingPhase 3
Polypill and colchicine for heart and artery risk
This trial tests a combination pill (polypill) and a medicine called colchicine to see if they can lower the risk of future heart attacks, strokes, or other artery problems. It is for people who already have a history of heart or blood vessel disease.
Maceió, AlabamaAges 45 years+ - NCT06839859RecruitingPhase 2
Family Acceptance Project online pilot study
This trial tests an online program called Family Acceptance Project to help LGBTQ+ youth of color and their families improve acceptance and reduce rejection. You and a caregiver will join separate online group sessions to learn communication and support skills.
Ann Arbor, MichiganAges 14 years+ - NCT06818669Recruiting
Heart risk study for Black adults with food insecurity
This study tests if giving small rewards for buying healthy food and taking medicines can lower heart disease risk in African American adults who have trouble getting enough food. You will get help with food costs and health coaching.
Buffalo, New YorkAges 18 years+ - NCT06785116RecruitingPhase 4
Study on dapagliflozin for heart health after a hypertensive pregnancy
This trial tests a medicine called dapagliflozin (DAPA) to see if it reduces heart risk in women who had high blood pressure or preeclampsia during pregnancy. It is designed for those who had severe blood pressure rises around delivery or a high BNP level, a marker of heart strain.
Ann Arbor, MichiganAges 18 years+ - NCT06741956Enrolling by invitation
Wearable device for osteoporosis prevention in women
This trial tests a wearable device designed to help prevent osteoporosis and reduce fracture risk in women who have recently gone through menopause. The goal is to see if the device can help you stay active and lower your chances of breaking a bone.
Seville, SpainAges 40 years+ - NCT06650488RecruitingPhase 4
Clopidogrel vs aspirin after staph bloodstream infection
This trial compares two blood-thinning medicines, clopidogrel and aspirin, to see which better prevents heart attacks and strokes in people who have had a staph infection in their blood. If you already take aspirin for heart or blood vessel problems, this study may help find the safest way to protect your heart.
St. John's, Newfoundland and LabradorAges 18 years+ - NCT06616506Recruiting
AI for cataracts in high myopia
This trial uses artificial intelligence to study cataracts in people with high myopia (very nearsighted). It aims to improve diagnosis and treatment planning for cataract surgery.
Shanghai, Shanghai MunicipalityAges Any age - NCT06547008RecruitingPhase 1
Suicide prevention training for army leaders
This study tests a suicide prevention training program for unit leaders and chaplains in the Connecticut Army National Guard. It aims to see if the training helps them better support soldiers in need.
Hartford, ConnecticutAges Any age - NCT06444360Recruiting
Program to reduce stimulant use and risky sex in young adults
This study tests a program to help sexually active young adults reduce stimulant use and risky sexual behavior. It involves online coaching sessions, and you can join from home if you have a private space and video chat access.
Los Angeles, CaliforniaAges 16–24 - NCT06413927Recruiting
Driver education study for teen learners in Pennsylvania
This study compares different types of driver training for teens who have a learner's permit. It may help you become a safer driver before you get your license.
Philadelphia, PennsylvaniaAges 16–17 - NCT06195306RecruitingPhase 2
Low dose tamoxifen and omega-3 for breast cancer prevention
This study tests whether low-dose tamoxifen (a breast cancer prevention drug) or omega-3 supplements can lower breast cancer risk in postmenopausal women who are overweight and have a higher chance of getting the disease. The study lasts about 6 months and involves blood draws and a breast fluid test to see how the treatment affects breast cells.
Kansas City, KansasAges 45–74 - NCT06184750RecruitingPhase 2
Finding the best tamoxifen dose to lower breast cancer risk
This trial tests different doses of tamoxifen to find the best one for lowering breast cancer risk in premenopausal women. It aims to see if a lower dose works as well as the standard dose with fewer side effects.
Tucson, ArizonaAges 18–55 - NCT06096688Recruiting
Finding new ways to lower colorectal and endometrial cancer risk
This study looks for new ways to lower the risk of colorectal and endometrial cancers. It collects tissue and information from people who are getting certain procedures or treatments at Weill Cornell Medicine.
New York, New YorkAges 18 years+ - NCT06052943Recruiting
Health Without Barriers: Teens and Families
This trial tests a program designed to help teens and families stay healthy. It is available for families living in certain counties in Colorado and aims to support overall well-being.
Durango, ColoradoAges 11–19 - NCT05889416Enrolling by invitation
Testing a new cardiac rehabilitation program for heart attack patients
This study checks how well a “perfect” version of cardiac rehabilitation (CR) works for people who had a type 1 heart attack. It may help improve follow-up care and outcomes by making CR delivery more consistent.
MalmöAges 18–79 - NCT05259150Enrolling by invitation
Health for Hearts program for Black adults
This study is testing a community health program aimed at improving heart health. It is designed specifically for Black adults and looks at whether the program is helpful for people like you.
Tallahassee, FloridaAges 18 years+ - NCT03971669RecruitingPhase 4
Blood donor study testing safety of donating in health
This trial studies people who donate blood and checks what happens in your body after donation, focusing on safety and measurements in lab tests. You may be able to join if you are healthy and pass screening labs and health history checks.
Baltimore, MarylandAges 18 years+ - NCT06214611Recruiting
Adaptive radiation therapy for head and neck tumors
This trial tests a special type of radiation therapy that can adjust to changes in your tumor during treatment. It's for people with head or neck tumors who are scheduled for radiation.
Essen, Germany / NRWAges 18 years+
Hear when a new Risk Reduction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for risk reduction?
- Yes. Clin2 currently lists 63 recruiting risk reduction studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a risk reduction trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a risk reduction trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.